The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article

Shepherd et al. 353 (2): 123, Figure 1     July 14, 2005


- Return to Article - Add to Personal Archive - PowerPoint Help



Figure 1. Kaplan–Meier Curves for Overall Survival (Panel A) and Progression-free Survival (Panel B) among All Patients Randomly Assigned to Erlotinib or Placebo.

P values were adjusted for stratification factors (except center) and epidermal growth factor receptor expression.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.